
    
      Before (baseline) and after tDCS or sham-tDCS treatment, subjects were examined:

      (1) clinically, regarding craving (obsessive compulsive scale) and relapses to the drug use.

      They were followed-up for clinical examination at least 60 days after treatment.
    
  